Nephros (NEPH) Cash from Financing Activities (2010 - 2026)
Nephros' (NEPH) quarterly Cash from Financing Activities came in at $289000.0 in Q1 2026, up 29000.0% year-on-year from N/an in Q1 2025, and up 29000.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Nephros (NEPH) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Nephros' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $289000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 29000.0% year-over-year to $289000.0 in Q1 2026; TTM through Mar 2026 was $285000.0, a 7225.0% increase from a year earlier, with the FY2025 full-year figure at -$5000.0, changed 0.0% from the prior year.
- Cash from Financing Activities grew to $289000.0 in Q1 2026 per NEPH's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $289000.0 in Q1 2026 and bottomed at -$111000.0 in Q4 2022.
- The 5-year median for Cash from Financing Activities is -$2000.0 (2023), against an average of $15600.0.
- Across the five-year window, Cash from Financing Activities slumped 250.0% in 2022 and jumped 29000.0% in 2026, its largest moves.
- Year by year, Cash from Financing Activities stood at -$111000.0 in 2022, then jumped by 97.3% to -$3000.0 in 2023, then jumped by 66.67% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025, then soared by 29000.0% to $289000.0 in 2026.
- Per Business Quant, the three latest NEPH Cash from Financing Activities figures stand at $289000.0 (Q1 2026), -$1000.0 (Q4 2025), and -$2000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 289,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |